FS301 - EAS/Hybrid Candidacy, Programming, and Outcomes

Friday, April 1, 2022

7:45 AM – 9:45 AM CT

Location: 130

Earn 0.2 CEUs

Lead Presenter(s)

René H. Gifford, PhD

Professor
Vanderbilt University Medical Center
Nashville, Tennessee

Disclosure: Financial Disclosures: Advanced Bionics- Consultant/Advisory Board, Research Grant includes principal investigator, collaborator or consultant and pending grants as well as grants already received; Akouos- Consultant/Advisory Board; Cochlear- Consultant/Advisory Board, Research Grant includes principal investigator, collaborator or consultant and pending grants as well as grants already received; Frequency Therapeutics- Consultant/Advisory Board
Non-Financial Disclosures: I do not have any relevant non-financial relationships with anything to disclose.

Presenter(s)

Camille C. Dunn, PhD

Director, Cochlear Implant Program
University of Iowa
Iowa City, Iowa

Disclosure: Financial Disclosures: I do not have any relevant financial relationships with anything to disclose.
Non-Financial Disclosures: I do not have any relevant non-financial relationships with anything to disclose.
Craig Buchman, MD

Professor and Chair
Washington University School of Medicine
St. Louis, Missouri

Disclosure: Financial Disclosures: Advanced Bionics- Consultant/Advisory Board; Advanced Cochlear Diagnostics, LLC- Ownership Interest includes stock, stock options, patent or other intellectual property; Cochlear Corporation- Consultant/Advisory Board; Envoy- Consultant/Advisory Board, Speaker/Honoraria; IotaMotion, Inc.- Consultant/Advisory Board, Speaker/Honoraria
Non-Financial Disclosures: I do not have any relevant non-financial relationships with anything to disclose.
Jillian B. Roberts, AuD

Hearts for Hearing, Oklahoma

Disclosure: Financial Disclosures: I do not have any relevant financial relationships with anything to disclose.
Non-Financial Disclosures: I do not have any relevant non-financial relationships with anything to disclose.

Abstract: Hearing preservation cochlear implantation is increasingly prevalent. The benefits of combined electric and acoustic stimulation (EAS) are well documented for speech recognition in noise, localization, music perception, and subjective listening difficulty. Despite the significant benefits documented for EAS listeners, referrals for EAS candidates constitute a small proportion of our prospective candidate population and EAS technology is underutilized for cochlear implant (CI) recipients with acoustic hearing preservation. Thus, this seminar will provide an overview of EAS candidacy—including EAS/Hybrid and conventional implant systems associated with acoustic hearing preservation—as well as EAS outcomes and data-driven guidance for EAS programming.

Learning Objectives:

Describe EAS candidacy criteria and the availability of both EAS/Hybrid systems and conventional CI systems which facilitate acoustic hearing preservation.
Apply research-based evidence to clinical practices regarding audiologic management of EAS technology focusing on programming of the HA and CI.
Describe the benefits associated with EAS listening for speech and music perception as well as various spatial hearing scenarios.